BAT CEO Warns Disposable E-Cigarette Ban Will Backfire

BAT by 2FIRSTS, edited by Sophia
Mar.26.2024
BAT CEO Warns Disposable E-Cigarette Ban Will Backfire
BAT CEO Tadeu Marroco believes the UK government's plan to ban disposable e-cigarettes will have unintended consequences.

According to a report by the BBC on March 25, Tadeu Marroco, the CEO of British American Tobacco (BAT), stated that banning disposable e-cigarettes would not be effective and that raising the smoking age limit would have "unintended consequences.

 

The British government plans to ban the sale of disposable e-cigarettes starting in April of next year, in what is being touted as the biggest public health measure in decades. Currently, BAT is the third largest e-cigarette sales company in the UK. Sales of disposable e-cigarettes have surged in recent years, with projections indicating that annual sales could reach into the billions, many of which are being sold illegally.

 

The British government announced a tobacco and e-cigarette law last week, which will prohibit individuals born after 2009 from purchasing tobacco and impose on-the-spot fines for retailers selling to those under 18.

 

However, Maroko stated that similar bans in other countries have not achieved the desired results. He said:

 

In other countries, the effectiveness of this policy is not ideal. In Australia, for example, a complete ban has led to high levels of purchases by teenagers in the illegal market, and Brazil has experienced a similar situation.

 

Deborah Arnott, Chief Executive of the anti-smoking charity organization Action on Smoking and Health (ASH), has expressed opposition to the ban on disposable products, stating that while it is feasible, strict regulation is necessary not only within shops but also to prevent illegal imports.

 

BAT, one of the largest publicly traded companies in the UK, ranks third in the disposable e-cigarette market. Chinese companies SKE and Heaven Gifts are the market leaders, manufacturing e-cigarette products including ELFBAR and Lost Mary.

 

Maroko agreed that stricter punishment measures are needed. He stated that the proposed on-the-spot fine of £100 "is not enough" and called for the implementation of France's proposed €100,000 (approximately £86,000) "appropriate fine".

 

However, he issued a warning against the government's plan to raise the legal smoking age limit each year, stating that those born in 2009 and later will never be able to legally purchase tobacco, which will have "unintended consequences" for retail and enforcement.

 

"We first need to address the issue of minors using e-cigarettes. We need to have retail licenses, just like we do for alcohol products," he reiterated the company's call to ban flavors that appeal to children, such as dessert and soft drink flavors.

 

When asked whether BAT only supports policies that align with the company's interests, the CEO replied, "This is an industry that has been under close scrutiny on how to reduce the impact of our products on health... This is the first time we have the technology to do this."

 

Mr. Marlboro defended the company's sponsorship activities, stating that they were "primarily targeted at adults" as they distributed free samples of their oral nicotine pouch products for promotional purposes. "We are very careful about this," he said. The UK Tobacco and E-cigarette Act will grant the government the power to regulate the sale of nicotine pouches.

 

When asked if the company has a say in regulating e-cigarettes, Mr. Maloco did not comment, but he said, "We have already discussed these issues in detail in the past, and they are now in the past...BAT now has the opportunity to reduce the risks of our products, which was not possible in the past."

 

Mrs. Arnot from ASH stated:

 

We have heard BAT say many times that they have changed, but BAT is still promoting traditional tobacco cigarettes...most of their profits still come from this. This is why they don't like government sales age legislation, not because it is ineffective, but because it is effective.

 

In a statement, the Department of Health and Social Care stated that approximately 80,000 people in the UK die from smoking each year, leading to a loss of £17 billion annually. The Tobacco and E-cigarette Bill is the largest public health measure in recent decades, aiming to protect future generations from the harm of smoking. It is expected to save thousands of lives and billions of pounds for our National Health Service, freeing up new resources to improve the overall health of the UK.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08